Blau Farmacêutica S.A. (BVMF:BLAU3)

Market Cap	2.56B +8.6%
Revenue (ttm)	1.70B -3.0%
Net Income	294.96M +35.8%
EPS	1.28 +35.8%
Shares Out	230.98M
PE Ratio	8.68
Forward PE	7.98
Dividend	0.36 (3.20%)
Ex-Dividend Date	Mar 24, 2026

Volume	188,900
Average Volume	358,830
Open	10.92
Previous Close	11.08
Day's Range	10.92 - 11.25
52-Week Range	8.72 - 11.58
Beta	0.38
RSI	62.51
Earnings Date	Mar 18, 2026

About Blau Farmacêutica

Blau Farmacêutica S.A., a pharmaceutical company provides drug products in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States. Its products cover various areas, such as immunology, hematology, oncology, nephrology, infectology, and anesthesiology. The company offers uterine stimulator, antirheumatic, anaesthetics, antibiotics, feminine health care, biopharmaceuticals, oncologicals, hospital products, antivirals and antiretrovirals, biológicos, acid pump inhibitor, hemoderivatives, antithrombotic, and thrombolytics...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1987
• Employees: 1,900
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: BLAU3

Financial Performance

In 2025, Blau Farmacêutica's revenue was 1.70 billion, a decrease of -2.96% compared to the previous year's 1.75 billion. Earnings were 294.96 million, an increase of 35.80%.